— No reduced risk of mechanical ventilation or death by Zaina Hamza Colchicine (Colcrys) didn't benefit patients hospitalized with moderate to severe COVID-19-related pneumonia, researchers found in the COLCOVID randomized trial. Among more than 1,200 COVID-19...
By Paul Anderson ND & Paul Herscu ND, MPH Whereas: 1. The Omicron variant transmission rate is very high, most likely due to increased airborne transmission, and 2. The Omicron variant is a...
By Chris Kresser with commentary from Mark Bricca, ND, MAc I believe this is one of the *very* most important email messages I've received during this entire pandemic. I agree 100% with Chris' analysis and conclusions. In my opinion, there is no sound...
— Group of physician-scientists believes data support authorization for treating COVID-19 by Sophie Putka t took about 4 days for David Boulware, MD, MPH, to write the FDA emergency use authorization (EUA) application for fluvoxamine. Yes, a doctor wrote an EUA...
A large group of South Africa-based scientists led by the Africa Health Research Institute recently uploaded study results that indicate the new super mutant of SARS-CoV-2, Omicron, strengthens the neutralizing immunity in response to the previously dominant Delta...
Authorities change guidelines based on ‘what we know about the spread’ and protection from vaccination, as expert warns US ‘being hit by a viral hurricane’ By Martin Pengelly US health authorities have halved, to five days, the recommended isolation time for people...
Paxlovid and molnupiravir were authorized by the US FDA last week, but supplies of Paxlovid are limited while molnupiravir is less effective than hoped By Melody Schreiber An effective and widely available treatment for Covid would be a significant breakthrough for...
Sir John Bell says disease ‘appears less severe’ as other scientists criticise lack of new restrictions in England By Jessica Murray Omicron is “not the same disease we were seeing a year ago” and high Covid death rates in the UK are “now history”, a leading...
By Sarah Al-Arshani Public health experts have previously said vaccine inequality would allow for new variants. A Texas doctor and his team developed Corbevax, a low-cost COVID-19 vaccine. The vaccine just received emergency use authorization in India. A Texas...
By Isabel Kershner An Israeli hospital on Monday began a study to test the safety and effectiveness of a fourth dose of a Covid-19 vaccine, as health officials continued to deliberate over rolling out fourth shots for vulnerable people nationwide. Officials...
Hoping to prevent further disruptions to daily life, the C.D.C. reduced the period that certain infected Americans must sequester. By Benjamin Mueller and Isabella Grullón Paz As daily coronavirus cases in the United States soared to near record levels, federal health...
A trio of scientists focusing on mitochondria research at the Ben-Gurion University of the Negev, Department of Life Sciences led by Dan Mishmar, Ph.D. suggest it could be the moment now to “rethink” COVID-19 as a pure respiratory condition, as the contagion may...
By Marc Tracy, Daniel Victor, Adeel Hassan and Ana Ley Flight disruptions in the United States showed few signs of abating on Monday as many people embarked on their first trips in almost two years, and Dr. Anthony S. Fauci, the nation’s top infectious disease expert,...
Dr Jen Green ND, FABNOwww.DrJenGreen.com Link to PDF This document is intended for educational purposes only and does not constitute medical care. Itdoes not recommend any treatments, nor have any of these modalities been proven effectiveagainst coronavirus. Always...
Originally published July 27, 2021 ~ MedTecs.com How long the virus survives depends on the material & external factorsHow long does COVID-19 survive in the air?How long does it live on surfaces?How Long Can The Coronavirus Live On Surfaces?How long does the virus...